[go: up one dir, main page]

PE20141639A1 - Proceso para preparar fumarato de dimetilo de alta pureza y cristalino - Google Patents

Proceso para preparar fumarato de dimetilo de alta pureza y cristalino

Info

Publication number
PE20141639A1
PE20141639A1 PE2013002765A PE2013002765A PE20141639A1 PE 20141639 A1 PE20141639 A1 PE 20141639A1 PE 2013002765 A PE2013002765 A PE 2013002765A PE 2013002765 A PE2013002765 A PE 2013002765A PE 20141639 A1 PE20141639 A1 PE 20141639A1
Authority
PE
Peru
Prior art keywords
smoke
high purity
preparing crystalline
crystalline high
purity dimethyl
Prior art date
Application number
PE2013002765A
Other languages
English (en)
Inventor
John Guzowski
William KIESMAN
Erwin Irdam
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20141639(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of PE20141639A1 publication Critical patent/PE20141639A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593—Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/60—Maleic acid esters; Fumaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/604—Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UN METODO PARA LA PREPARACION DE FUMARATO DE DIMETILO, QUE COMPRENDE: HACER REACCIONAR ACIDO FUMARICO Y METANOL EN PRESENCIA DE ACIDO SULFURICO, EN UNA MEZCLA DE REACCION PARA OBTENER UNA MEZCLA DEL PRODUCTO QUE COMPRENDE UN NIVEL BAJO DE SULFATO DE DIMETILO, DONDE DICHO SULFATO DE DIMETILO ES MENOR QUE 4,0 ppm; ADICIONALMENTE SE REDUCE EL TAMANO DE PARTICULA DEL FUMARATO DE DIMETILO A UN TAMANO QUE VARIA DE 20�m A 250�m. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA
PE2013002765A 2011-06-08 2012-06-08 Proceso para preparar fumarato de dimetilo de alta pureza y cristalino PE20141639A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161494775P 2011-06-08 2011-06-08

Publications (1)

Publication Number Publication Date
PE20141639A1 true PE20141639A1 (es) 2014-11-08

Family

ID=47296498

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002765A PE20141639A1 (es) 2011-06-08 2012-06-08 Proceso para preparar fumarato de dimetilo de alta pureza y cristalino

Country Status (32)

Country Link
US (1) US9422226B2 (es)
EP (1) EP2718257B1 (es)
JP (3) JP6385273B6 (es)
KR (2) KR20140035995A (es)
CN (1) CN103649041A (es)
AU (1) AU2012267524A1 (es)
BR (1) BR112013031616A2 (es)
CA (1) CA2838271A1 (es)
CL (1) CL2013003483A1 (es)
CO (1) CO6821956A2 (es)
CY (1) CY1119920T1 (es)
DK (1) DK2718257T3 (es)
EA (1) EA201391638A1 (es)
EC (1) ECSP14013123A (es)
ES (1) ES2659771T3 (es)
HR (1) HRP20180203T1 (es)
HU (1) HUE036085T2 (es)
IL (1) IL229656A0 (es)
LT (1) LT2718257T (es)
ME (1) ME02960B (es)
MX (1) MX355421B (es)
NO (1) NO2820009T3 (es)
NZ (1) NZ618178A (es)
PE (1) PE20141639A1 (es)
PH (1) PH12013502498A1 (es)
PL (1) PL2718257T3 (es)
PT (1) PT2718257T (es)
RS (1) RS56972B1 (es)
SG (1) SG195227A1 (es)
SI (1) SI2718257T1 (es)
SM (1) SMT201800098T1 (es)
WO (1) WO2012170923A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004010531T2 (de) 2003-09-09 2008-07-03 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
EP3093012A1 (en) 2004-10-08 2016-11-16 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
CA2730478C (en) 2008-08-19 2014-04-15 Xenoport, Inc. Prodrugs of methyl hydrogen fumarate
ME02960B (me) 2011-06-08 2018-07-20 Biogen Ma Inc Postupak za pripremu visoko-čistog i kristalnog dimetil fumarata
JP2015527372A (ja) 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
EP2887935A1 (en) 2012-08-22 2015-07-01 XenoPort, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
JP6506174B2 (ja) 2012-12-21 2019-04-24 バイオジェン エムエー インコーポレイテッド 重水素置換されたフマル酸誘導体
WO2014152494A1 (en) 2013-03-14 2014-09-25 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various deseases
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
CN104098471A (zh) * 2013-04-03 2014-10-15 南京卡文迪许生物工程技术有限公司 富马酸二甲酯多晶型物及其制备方法和药物组合物
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (en) 2013-06-21 2014-12-24 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート，インコーポレイティド （ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
IN2013MU03070A (es) * 2013-09-25 2015-07-17 Glenmark Pharmaceuticals Ltd
IN2014CH00308A (es) * 2014-01-24 2015-07-31 Shilpa Medicare Ltd
WO2015127450A1 (en) 2014-02-24 2015-08-27 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
WO2015130998A1 (en) 2014-02-28 2015-09-03 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
ES2777273T3 (es) * 2014-03-17 2020-08-04 Biophore India Pharmaceuticals Pvt Ltd Procedimiento mejorado para la síntesis de dimetil fumarato
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016001093A1 (en) * 2014-07-03 2016-01-07 Synthon B.V. Process for making microcrystalline dimethyl fumarate
CN104151165B (zh) * 2014-08-11 2016-08-24 广东东阳光药业有限公司 制备富马酸二甲酯的方法
CN104761453A (zh) * 2015-04-22 2015-07-08 河南中帅医药科技股份有限公司 一种富马酸二甲酯晶型及其制备方法
AU2016273068A1 (en) * 2015-06-01 2017-12-21 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
MX387092B (es) * 2015-06-17 2025-03-19 Biogen Ma Inc Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
CN106316841A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种富马酸二甲酯的制备方法
WO2017013672A1 (en) * 2015-07-23 2017-01-26 Natco Pharma Ltd Process for the preparation of pharmaceutical grade dimethyl fumarate
US10011663B2 (en) 2016-02-04 2018-07-03 Eastman Chemical Company Vulcanizing composition containing cyclododecasulfur and improved cyclododecasulfur compound
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
CN107285320A (zh) * 2017-08-02 2017-10-24 内蒙古新福地科技有限公司 一种氟硅酸钠的结晶方法及装置
DK3694863T3 (da) * 2017-10-10 2023-07-03 Pfizer Krystallinsk form af frit basehydrat af lorlatinib
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
KR102271575B1 (ko) * 2020-09-16 2021-07-01 김갑용 염의 이온교환법을 이용한 친환경 고효율 에스터화반응 기반의 에스터화합물 제조방법 및 이의 화합물
JP6865489B1 (ja) * 2020-10-20 2021-04-28 株式会社エス・ディー・エス バイオテック ２，３，５，６−テトラクロロ−１，４−ベンゼンジカルボン酸ジメチルの製造方法

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) 1932-03-08 Alphons
US2764609A (en) * 1953-07-24 1956-09-25 Monsanto Chemicals Isomerization of dialkyl maleates to dialkyl fumarates
US3078302A (en) * 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
US3993684A (en) 1971-08-20 1976-11-23 Western Litho Plate & Supply Co. Monomeric compounds
US4568756A (en) 1976-09-24 1986-02-04 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4239636A (en) 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4866187A (en) 1976-09-24 1989-09-12 Exxon Research & Engineering Company Thio-bis(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4417062A (en) 1976-09-24 1983-11-22 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US5118835A (en) 1976-09-24 1992-06-02 Exxon Research & Engineering Co. Thio-bis(alkyl lactone acid esters) and thio-bis (Hydrocarbyl diacid esters) are usefull additives for lubricating compositions
US4965375A (en) 1976-09-24 1990-10-23 Exxon Research And Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
JPS60193946U (ja) 1984-03-01 1985-12-24 内山　茂夫 変色炎を有するろうそく
JPS60193946A (ja) * 1984-03-16 1985-10-02 Nippon Oil & Fats Co Ltd ジイソプロピルフマレ−トの製造法
CH664150A5 (de) 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
US5149695A (en) 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
JPS61246147A (ja) * 1985-04-22 1986-11-01 Nippon Shokubai Kagaku Kogyo Co Ltd マレイン酸ジアルキルエステルの精製方法
US4954277A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified, esterified or aminated additives useful in oleaginous compositions and compositions containing same
US4906394A (en) 1986-10-07 1990-03-06 Exxon Chemical Patents Inc. Lactone modified mono-or dicarboxylic acid based adduct dispersant compositions
US4954276A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4866139A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified, esterified dispersant additives useful in oleaginous compositions
US4866140A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4963275A (en) 1986-10-07 1990-10-16 Exxon Chemical Patents Inc. Dispersant additives derived from lactone modified amido-amine adducts
US5032320A (en) 1986-10-07 1991-07-16 Exxon Chemical Patents Inc. Lactone modified mono- or dicarboxylic acid based adduct dispersant compositions
DE3711155A1 (de) * 1987-04-02 1988-10-13 Bayer Ag Verfahren zur herstellung von maleinsaeuredimethylester
US4820432A (en) 1987-07-24 1989-04-11 Exxon Chemical Patents Inc. Lactone-modified, Mannich base dispersant additives useful in oleaginous compositions
US4971711A (en) 1987-07-24 1990-11-20 Exxon Chemical Patents, Inc. Lactone-modified, mannich base dispersant additives useful in oleaginous compositions
US4959389A (en) 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
US4943382A (en) 1988-04-06 1990-07-24 Exxon Chemical Patents Inc. Lactone modified dispersant additives useful in oleaginous compositions
US5153352A (en) 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
EP0608020B1 (en) 1993-01-21 1997-06-11 Akzo Nobel N.V. Air-drying aqueous polymer dispersions
CN1103398A (zh) * 1993-11-30 1995-06-07 张治明 一种由顺酐生产富马酸二甲酯的工艺方法
AU3881695A (en) 1994-11-21 1996-06-17 Asahi Kasei Kogyo Kabushiki Kaisha Curable resin and composition
CA2258875A1 (en) 1996-06-24 1997-12-31 Cytec Technology Corp. Polymerizable urea/ureido functional monomers
US6239189B1 (en) 1997-04-01 2001-05-29 Henkel Corporation Radiation-polymerizable composition and printing inks containing same
DE19721099C2 (de) 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
US6204410B1 (en) 1997-07-11 2001-03-20 Showa Denko Kabushiki Kaisha Ether compounds and process for producing the same
US6376702B1 (en) 1997-07-11 2002-04-23 Showa Denko K.K. Ether compound, production thereof and curable compositions
GB9724004D0 (en) 1997-11-13 1998-10-21 Kvaerner Process Tech Ltd Process
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19839566C2 (de) 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
WO2001048084A1 (fr) 1999-12-27 2001-07-05 Asahi Kasei Kabushiki Kaisha Composition de resine polyoxymethylene
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
AU3228301A (en) 2000-02-15 2001-08-27 Showa Denko Kabushiki Kaisha Process for producing fumaric ester
JP2001281800A (ja) 2000-03-31 2001-10-10 Konica Corp 熱現像写真感光材料
US6586452B1 (en) 2000-07-14 2003-07-01 Merck & Co., Inc. C1 to C4 side chain modified nodulisporic acid analogs
US20020098451A1 (en) 2000-09-07 2002-07-25 Tadashi Arimoto Photothermographic material
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
WO2002055063A2 (de) 2001-01-12 2002-07-18 Fumapharm Ag Fumarsäureamide
JP2003160535A (ja) * 2001-11-28 2003-06-03 Nof Corp 不飽和二塩基酸ジエステルの製造方法
EP2105431A1 (en) 2002-02-28 2009-09-30 Sumitomo Chemical Company, Limited Process for Producing Chromone Compound
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
JP2003315960A (ja) 2002-04-25 2003-11-06 Konica Minolta Holdings Inc 銀塩光熱写真ドライイメージング材料
JP4259815B2 (ja) 2002-06-06 2009-04-30 ダイセル化学工業株式会社 高純度酢酸ブチルの製造方法
DE602004010531T2 (de) 2003-09-09 2008-07-03 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
JP4163653B2 (ja) 2004-02-27 2008-10-08 株式会社日本触媒 光学部品用硬化性組成物
US7557241B2 (en) 2004-08-30 2009-07-07 Sanyo Chemical Industries, Ltd. Method for producing α,β-unsaturated carboxylic acid ester, α,β-unsaturated carboxylic acid ester, and lubricating oil additive
EP3093012A1 (en) 2004-10-08 2016-11-16 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
TWI279403B (en) * 2004-10-20 2007-04-21 Eternal Chemical Co Ltd Cyclobutanetetracarboxylate compound and preparation method thereof
WO2006050730A1 (en) 2004-11-10 2006-05-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
MX2007007040A (es) 2004-12-17 2008-10-24 Metanomics Gmbh Proceso para el control de produccion de productos quimicos finos.
CN101147100B (zh) 2005-04-22 2010-09-29 佳能株式会社 磁性调色剂
DE102005022845A1 (de) 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung
EP1915334A2 (en) 2005-07-07 2008-04-30 Aditech Pharma AB Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
WO2007020734A1 (ja) 2005-08-12 2007-02-22 Lion Corporation ナノ平滑性とエッチング耐性を有するフォトレジストポリマーならびにレジスト組成物
WO2007042035A2 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
EP1951206A1 (en) 2005-10-07 2008-08-06 Aditech Pharma AB Controlled release pharmaceutical compositions comprising a fumaric acid ester
CN101466273A (zh) 2006-06-16 2009-06-24 古木林科有限公司 包含疏水酶制剂的口香糖
SI2653873T1 (sl) 2007-02-08 2022-09-30 Biogen Ma Inc. Sestave in načini uporabe za zdravljenje multiple skleroze
US20100130607A1 (en) 2007-02-08 2010-05-27 Ralf Gold Neuroprotection in demyelinating diseases
TWI525195B (zh) 2007-08-10 2016-03-11 奇諾麥提卡公司 合成烯酸及其衍生物之方法
EP2219783B1 (en) 2007-10-26 2017-10-11 Purolite International, Ltd. Controlled catalysis
WO2009075303A1 (ja) 2007-12-12 2009-06-18 Mitsubishi Chemical Corporation 脂肪族ポリエステル樹脂及びその製造方法
CN102369001A (zh) 2009-01-09 2012-03-07 前进制药公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
US20120165404A1 (en) 2009-04-29 2012-06-28 Biogen Idec Ma Inc. Treatment of neurodegeneration and neuroinflammation
WO2011017543A1 (en) 2009-08-07 2011-02-10 Invista Technologies S.A. R.L. Hydrogenation and esterification to form diesters
ES2555279T3 (es) 2010-02-12 2015-12-30 Biogen Ma Inc. Neuroprotección en enfermedades desmielinizantes
CN102757346A (zh) 2011-04-26 2012-10-31 中国科学院兰州化学物理研究所 一种富马酸二甲酯的制备方法
CN103732062A (zh) 2011-05-26 2014-04-16 比奥根艾迪克Ma公司 治疗多发性硬化以及保持和/或增加髓磷脂含量的方法
ME02960B (me) 2011-06-08 2018-07-20 Biogen Ma Inc Postupak za pripremu visoko-čistog i kristalnog dimetil fumarata
CN102432464A (zh) 2011-12-14 2012-05-02 费近峰 一种富马酸二甲酯的连续生产工艺
AU2013203445C1 (en) 2012-02-07 2017-04-20 Biogen Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
CN102766050A (zh) 2012-08-10 2012-11-07 太仓市运通化工厂 一种富马酸二甲酯的合成方法
JP6506174B2 (ja) 2012-12-21 2019-04-24 バイオジェン エムエー インコーポレイテッド 重水素置換されたフマル酸誘導体
CN103848739A (zh) 2014-03-20 2014-06-11 徐晓宁 一种高纯度富马酸二甲酯的生产方法

Also Published As

Publication number Publication date
ME02960B (me) 2018-07-20
MX2013014320A (es) 2014-01-31
RS56972B1 (sr) 2018-05-31
EP2718257B1 (en) 2017-11-15
BR112013031616A2 (pt) 2016-12-06
DK2718257T3 (en) 2018-02-12
SI2718257T1 (en) 2018-04-30
IL229656A0 (en) 2014-01-30
CN103649041A (zh) 2014-03-19
NZ618178A (en) 2016-03-31
NO2820009T3 (es) 2018-06-30
JP6385273B2 (ja) 2018-09-05
EA201391638A1 (ru) 2014-05-30
SG195227A1 (en) 2013-12-30
US9422226B2 (en) 2016-08-23
CO6821956A2 (es) 2013-12-31
SMT201800098T1 (it) 2018-03-08
JP2016155868A (ja) 2016-09-01
ES2659771T3 (es) 2018-03-19
EP2718257A1 (en) 2014-04-16
PL2718257T3 (pl) 2018-04-30
HUE036085T2 (hu) 2018-06-28
MX355421B (es) 2018-04-18
JP2018162266A (ja) 2018-10-18
AU2012267524A1 (en) 2013-12-12
HRP20180203T1 (hr) 2018-04-06
LT2718257T (lt) 2018-03-12
ECSP14013123A (es) 2014-06-30
CY1119920T1 (el) 2018-06-27
CL2013003483A1 (es) 2014-05-09
JP6385273B6 (ja) 2023-12-15
EP2718257A4 (en) 2015-08-12
US20140200363A1 (en) 2014-07-17
WO2012170923A1 (en) 2012-12-13
JP2014522413A (ja) 2014-09-04
KR20150080037A (ko) 2015-07-08
PT2718257T (pt) 2018-02-26
PH12013502498A1 (en) 2014-01-20
CA2838271A1 (en) 2012-12-13
KR20140035995A (ko) 2014-03-24

Similar Documents

Publication Publication Date Title
PE20141639A1 (es) Proceso para preparar fumarato de dimetilo de alta pureza y cristalino
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
MX343501B (es) Procedimiento para producir acido acetico.
BR112012024538A2 (pt) processo para preparar um produto de carbonato de cálcio precipitado, material e uso do produto de carbonato de cálcio precipitado.
CL2013003267A1 (es) Un proceso para la elaboracion de un producto de carbonato de ion metalico divalente precipitado de desecho de la molienda de pulpa que tiene brillo mejorado.
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JO3218B1 (ar) إنتاج كربونات كالسيوم مترسبة عالية النقاوة
MY167395A (en) Method for producing glufosinate p free acid
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
MX2013011402A (es) Procedimiento para preparar soluciones acuosas de sales trialcalinometalicas de acido metilglicin - n, n - diacetico.
MX2012013610A (es) Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina.
CO6511211A2 (es) Composiciones estable de sns 595 y métodos de preparación
PL413013A1 (pl) Sposób recyklingu metanolu w procesie wytwarzania szczawianu dimetylu z gazu syntezowego
DOP2011000007A (es) Produccion de concetrados de sulfato de cinc de una solucion diluida de sulfato de cinc.
MY153094A (en) Process for separating acrylic acid present as a main constituent and glyoxal present as a by-product in a product gas mixture of a partial heterogeneously catalyzed gas phase oxidation of a c3 precursor compound of acrylic acid
EA201990236A1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
MA34990B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
AR095548A1 (es) Preparación de ácido 4-amino-2,4-dioxobutanoico
FR2984319B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2016105107A3 (ko) 무수당 알코올의 효과적인 생산 및 정제 방법
ES2570231A2 (es) Proceso para la preparacion de alcoholes superiores a partir de etanol y n-hexanol mediante condensacion de guerbet
MA35597B1 (fr) Nouveau procédé de synthése du 3-(2-bromo-4,5-dimethoxyphezyl) propanenitrile et application a la synthese de l'ivabradine et de ses sels d"addition a u acide pharmaceutiquemebnt acceptable
FR2984320B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
NZ726674A (en) Method for the preparation of (s)-2-acetyloxypropionic acid and derivatives thereof
CN102757321B (zh) 2,6-二甲氧基萘的生产方法

Legal Events

Date Code Title Description
FC Refusal